BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $260,089 | -29.6% | 5,179 | -11.4% | 0.16% | -27.9% |
| Q2 2023 | $369,594 | +24.6% | 5,848 | -11.3% | 0.22% | +34.4% |
| Q1 2023 | $296,619 | +4.6% | 6,593 | +1.8% | 0.16% | +10.1% |
| Q4 2022 | $283,626 | -16.6% | 6,474 | +25.3% | 0.15% | +8.8% |
| Q3 2022 | $340,000 | +32.3% | 5,165 | +1.5% | 0.14% | +43.2% |
| Q2 2022 | $257,000 | +7.1% | 5,089 | +35.3% | 0.10% | -11.2% |
| Q1 2022 | $240,000 | -40.4% | 3,762 | 0.0% | 0.11% | -29.6% |
| Q4 2021 | $403,000 | -26.1% | 3,762 | -29.0% | 0.15% | -36.7% |
| Q3 2021 | $545,000 | +7.1% | 5,302 | -8.4% | 0.24% | +14.8% |
| Q2 2021 | $509,000 | -1.9% | 5,786 | +8.5% | 0.21% | -4.6% |
| Q1 2021 | $519,000 | -10.8% | 5,334 | +2.8% | 0.22% | -9.5% |
| Q4 2020 | $582,000 | -24.9% | 5,188 | -38.0% | 0.24% | -40.4% |
| Q3 2020 | $775,000 | +29.8% | 8,362 | +9.2% | 0.41% | +43.5% |
| Q2 2020 | $597,000 | +111.0% | 7,658 | +58.4% | 0.28% | +144.0% |
| Q1 2020 | $283,000 | -36.3% | 4,836 | -12.7% | 0.12% | +58.9% |
| Q4 2019 | $444,000 | +116.6% | 5,540 | +98.1% | 0.07% | +78.0% |
| Q3 2019 | $205,000 | -26.3% | 2,796 | -5.3% | 0.04% | -30.5% |
| Q2 2019 | $278,000 | -26.8% | 2,951 | -37.8% | 0.06% | -92.7% |
| Q1 2019 | $380,000 | +31.5% | 4,741 | -11.6% | 0.81% | +1551.0% |
| Q4 2018 | $289,000 | -41.4% | 5,364 | -15.1% | 0.05% | -3.9% |
| Q3 2018 | $493,000 | -28.3% | 6,320 | -41.7% | 0.05% | -91.6% |
| Q2 2018 | $688,000 | -25.2% | 10,840 | +8.1% | 0.61% | -23.8% |
| Q1 2018 | $920,000 | +164.4% | 10,029 | +117.5% | 0.80% | +82.6% |
| Q4 2017 | $348,000 | -41.2% | 4,611 | -45.7% | 0.44% | +446.2% |
| Q3 2017 | $592,000 | +51.4% | 8,495 | +10.1% | 0.08% | +37.9% |
| Q2 2017 | $391,000 | -8.4% | 7,718 | -27.8% | 0.06% | -23.7% |
| Q1 2017 | $427,000 | +57.6% | 10,690 | +10.6% | 0.08% | -6.2% |
| Q4 2016 | $271,000 | -30.0% | 9,665 | -25.9% | 0.08% | -56.7% |
| Q3 2016 | $387,000 | +46.6% | 13,046 | 0.0% | 0.19% | -4.6% |
| Q2 2016 | $264,000 | +39.7% | 13,046 | +24.4% | 0.20% | -24.6% |
| Q1 2016 | $189,000 | – | 10,484 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |